Earnings
Home›Earnings›Previews›Kenvue analysts expect EPS growth as stock lags peers
Kenvue analysts expect EPS growth as stock lags peers
Kenvue (KVUE) is valued at $37.4 billion, and analysts project 2026 EPS of $1.16, up 7.4% year over year.
Kenvue Inc., the Summit, New Jersey-based consumer health company, trades with a consensus rating of “Hold” among 13 analysts, with expectations shaped by a turnaround effort after a weak period for parts of its portfolio, according to Yahoo Finance.
The stock has fallen 11.7% over the past 52 weeks, while growing 14.5% year to date, and it has lagged the State Street Consumer Staples Select Sector SPDR ETF (XLP), which rose 7.9% over the same 52-week span.
Investors have previously been concerned about sluggish sales growth, especially in the Skin Health & Beauty segment, where brands including Neutrogena and Aveeno faced weak consumer demand and competition, along with pressure from retailer inventory reductions and discretionary spending.
For the current year ending in December, analysts expect Kenvue earnings per share to rise 7.4% year over year to $1.16, and the company has topped analysts’ consensus estimates in each of the past four quarters, the outlet reported.